View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Lazertinib 240 / Amivantamab 1050, Non-Small Cell Lung Cancer, Cycle 2+
Protocol-ID: 2838 V1.0 (Mini), LAZE240/AMIV1050, NSCLC, C2+Indication(s)
- Lung Carcinoma, Non-Small Cell (EGFR exon 19 deletion mutation, EGFR exon 21 Leu858Arg mutation); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 13.03.2025